BIOMARKER:

EREG overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EREG overexpression	Colorectal Cancer	EREG overexpression	Colorectal Cancer	panitumumab Sensitive: B - Late Trials panitumumab Sensitive : B	panitumumab Sensitive: B - Late Trials panitumumab Sensitive : B
EREG overexpression	Colorectal Cancer	EREG overexpression	Colorectal Cancer	EGFR inhibitor Sensitive: C3 – Early Trials EGFR inhibitor Sensitive : C3	EGFR inhibitor Sensitive: C3 – Early Trials EGFR inhibitor Sensitive : C3
EREG overexpression	Pancreatic Cancer	EREG overexpression	Pancreatic Cancer	cetuximab Resistant: C4 – Case Studies cetuximab Resistant : C4	cetuximab Resistant: C4 – Case Studies cetuximab Resistant : C4